Fortress Biotech, Inc. (FBIO) vs Gossamer Bio, Inc. (GOSS)

A side-by-side comparison of Fortress Biotech, Inc. and Gossamer Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIO vs GOSS

growth of $100 · dividends reinvested · last 8y
FBIO -93.5% (-28.9%/yr)GOSS -99.3% (-45.8%/yr)FBIO compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$7$1
FBIO GOSS

FBIO vs GOSS: by the numbers

  • •FBIO is the larger company ($69M vs $65M market cap).
  • •FBIO is profitable (163.32% net margin) while GOSS runs a net loss (-235.00%).

Metrics side by side

Valuation

MetricFBIOGOSS
P/E ratio0.77N/A
P/S ratio1.001.22
P/B ratio0.42N/A
FCF yield183.45%N/A

Profitability

MetricFBIOGOSS
Gross margin62.53%99.56%
Operating margin-111.00%-336.81%
Net margin163.32%-235.00%
ROE68.12%N/A
ROIC-10.85%N/A

Growth (annualized)

MetricFBIOGOSS
Revenue CAGR (5Y)5.39%N/A
Total return CAGR (5Y)-46.06%-59.51%

Frequently asked

Is FBIO or GOSS more profitable?
FBIO runs the higher net margin — FBIO at 163.32% versus GOSS at -235.00%.
How have FBIO and GOSS total returns compared?
Over the past 5 years, FBIO delivered -46.06% and GOSS delivered -59.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.